Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 16, Issue 5, 2018, Pages 648-663.e3

  de Jong, Marin J ^a   Huibregtse, Roxanne ^a   Masclee, Ad A M ^a   Jonkers, Daisy M A E ^a   Pierik, Marie J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HBI; IBD; Marker; PRO2; SCCAI

Indexed keywords

6 POINT MAYO SCORE; AREA UNDER THE CURVE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; CROHN DISEASE; DISEASE ACTIVITY; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL ENDOSCOPY; HARVEY BRADSHAW INDEX AND SIMPLE CLINICAL COLITIS ACTIVITY INDEX SCORE; HEALTH PROGRAM; HUMAN; PATIENT-REPORTED OUTCOME; POPULATION RESEARCH; PRACTICE GUIDELINE; QUESTIONNAIRE; RELIABILITY; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL TRIAL (TOPIC); DRUG MONITORING; FEMALE; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL TRIALS AS TOPIC; DRUG MONITORING; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PATIENT REPORTED OUTCOME MEASURES; YOUNG ADULT;

EID: 85045569916     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.10.019     Document Type: Review

References (30)

1. Burisch, J., Munkholm, P., The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 50 (2015), 942–951.
2. Colombel, J.F., Narula, N., Peyrin-Biroulet, L., Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology 152 (2017), 351–361.
3. Molodecky, N.A., Soon, I.S., Rabi, D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54 quiz e30.
4. Jackson, B.D., Gray, K., Knowles, S.R., et al. EHealth technologies in inflammatory bowel disease: a systematic review. J Crohns Colitis 10 (2016), 1103–1121.
5. Bradley, S.M., Rumsfeld, J.S., Ho, P.M., Incorporating health status in routine care to improve health care value: the VA Patient Reported Health Status Assessment (PROST) System. JAMA 316 (2016), 487–488.
6. van Deen, W.K., Esrailian, E., Hommes, D.W., Value-based health care for inflammatory bowel diseases. J Crohns Colitis 9 (2015), 421–427.
7. Williet, N., Sandborn, W.J., Peyrin-Biroulet, L., Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 12 (2014), 1246–1256.
8. US Food and Drug Administration (FDA). Department of Health and Human Services (US) FDA CfDEaRC. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009.
9. Jowett, S.L., Seal, C.J., Phillips, E., et al. Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol 38 (2003), 164–171.
10. Bewtra, M., Brensinger, C.M., Tomov, V.T., et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflamm Bowel Dis 20 (2014), 1070–1078.
11. Lewis, J.D., Chuai, S., Nessel, L., et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 14 (2008), 1660–1666.
12. Clara, I., Lix, L.M., Walker, J.R., et al. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 104 (2009), 1754–1763.
13. Timmer, A., Kemptner, D., Takses, A., et al. A survey-based index was validated for measuring disease activity in inflammatory bowel disease. An evaluation study. J Clin Epidemiol 62 (2009), 771–778.
14. Lee, J.J., Colman, R.J., Mitchell, P.D., et al. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr 52 (2011), 708–713.
15. Turner, D., Griffiths, A.M., Mack, D., et al. Assessing disease activity in ulcerative colitis: patients or their physicians?. Inflamm Bowel Dis 16 (2010), 651–656.
16. Bennebroek Evertsz, F., Nieuwkerk, P.T., Stokkers, P.C., et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis 7 (2013), 890–900.
17. Bennebroek Evertsz, F., Hoeks, C.C., Nieuwkerk, P.T., et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity. J Clin Gastroenterol 47 (2013), 850–856.
18. Surti, B., Spiegel, B., Ippoliti, A., et al. Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale. Dig Dis Sci 58 (2013), 1313–1321.
19. Van Deen, W.K., van der Meulen-de Jong, A.E., Parekh, N.K., et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol 14 (2016), 1742–1750.
20. Jairath, V., Khanna, R., Zou, G.Y., et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther 42 (2015), 1200–1210.
21. Khanna, R., Zou, G., D'Haens, G., et al. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity. Aliment Pharmacol Ther 41 (2015), 77–86.
22. Subramanian, S., Asher, R., Weston, W., et al. Validation of a simple 0 to 10 numerical score (IBD-10) of patient-reported inflammatory bowel disease activity for routine clinical use. Inflamm Bowel Dis 22 (2016), 1902–1907.
23. Gracie, D.J., Williams, C.J., Sood, R., et al. Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. Am J Gastroenterol 111 (2016), 541–551.
24. Marin-Jimenez, I., Nos, P., Domenech, E., et al. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC Study. Am J Gastroenterol 111 (2016), 261–268.
25. Larsen, L., Drewes, A.M., Fallingborg, J., et al. Touch screens as a tool in patient care in the IBD outpatient clinic. Scand J Gastroenterol 51 (2016), 1106–1110.
26. Marin-Jimenez, I., Nos, P., Domenech, E., et al. Corrigendum: diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study. Am J Gastroenterol, 111, 2016, 912.
27. Colombel, J.F., Keir, M.E., Scherl, A., et al. Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC. Gut 66 (2017), 2063–2068.
28. Baars, J.E., Nuij, V.J., Oldenburg, B., et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis 18 (2012), 1634–1640.
29. Jharap, B., Sandborn, W.J., Reinisch, W., et al. Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis. Aliment Pharmacol Ther 42 (2015), 1082–1092.
30. Peyrin-Biroulet, L., Reinisch, W., Colombel, J.F., et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 63 (2014), 88–95.